​

Telix Pharmaceuticals (TLX) Stock Forecast, Price Target & Predictions

OverviewChartTranscripts

TLX Stock Forecast

Telix Pharmaceuticals (TLX) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a 82.65% increase from the last price of $10.95.

TLX Stock Rating

Telix Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

TLX Price Target Upside V Benchmarks

TypeNameUpside
StockTelix Pharmaceuticals82.65%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-22
Avg Price Target-$20.00$20.00
Last Closing Price$10.95$10.95$10.95
Upside/Downside-82.65%82.65%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2514---5
Sep, 2513---4
Aug, 2513---4
Jul, 25-2---2
Jun, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2025Laura SutcliffeUBS$20.00$10.9283.15%82.65%
Sep 10, 2025Robert BurnsH.C. Wainwright$20.00$9.69106.40%82.65%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 23, 2025UBSBuyBuyhold
Sep 18, 2025CitigroupBuyinitialise
Sep 10, 2025H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported-------
Avg Forecast$0.06$0.15$0.43$0.82$0.83$1.44$1.57
High Forecast$0.07$0.21$0.64$1.08$1.56$1.61$1.75
Low Forecast$0.05$0.12$0.25$0.56$0.55$1.30$1.42
Surprise %-------

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$502.55M$783.21M-----
Avg Forecast$335.87M$485.11M$830.71M$1.09B$1.29B$1.48B$1.67B
High Forecast$365.98M$486.23M$836.79M$1.24B$1.40B$1.61B$1.82B
Low Forecast$310.84M$483.98M$824.60M$957.05M$1.19B$1.37B$1.54B
Surprise %49.63%61.45%-----

Net Income Forecast

$0 $10M $20M $30M $40M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.21M$49.92M-----
Avg Forecast$686.14K$1.85M$5.11M$9.36M$12.04M$16.49M$17.93M
High Forecast$766.09K$2.38M$7.36M$12.30M$17.79M$18.41M$20.02M
Low Forecast$619.66K$1.32M$2.86M$6.42M$6.28M$14.89M$16.19M
Surprise %659.47%2601.64%-----

TLX Forecast FAQ

Is Telix Pharmaceuticals stock a buy?

Telix Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Telix Pharmaceuticals is a favorable investment for most analysts.

What is Telix Pharmaceuticals's price target?

Telix Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential 82.65% change from the previous closing price of $10.95.

How does Telix Pharmaceuticals stock forecast compare to its benchmarks?

Telix Pharmaceuticals's stock forecast shows a 82.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Telix Pharmaceuticals over the past three months?

  • October 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Telix Pharmaceuticals’s EPS forecast?

Telix Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $0.43, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $0.82 in 2026, $0.83 in 2027, $1.44 in 2028, and $1.57 in 2029.

What is Telix Pharmaceuticals’s revenue forecast?

Telix Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $830.71M, reflecting a 6.06% increase from the reported $783.21M in 2024. The forecast for 2026 is $1.09B, followed by $1.29B for 2027, $1.48B for 2028, and $1.67B for 2029.

What is Telix Pharmaceuticals’s net income forecast?

Telix Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $5.11M, representing a -89.76% decrease from the reported $49.92M in 2024. Projections indicate $9.36M in 2026, $12.04M in 2027, $16.49M in 2028, and $17.93M in 2029.